dehydroepiandrosterone has been researched along with camptothecin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, J; Guan, Z; Huang, Y; Huang, Z; Lai, H; Xiao, Z; Xu, C; Xu, X; Yang, H; Zhang, T; Zhao, C | 1 |
2 other study(ies) available for dehydroepiandrosterone and camptothecin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Reduction-responsive dehydroepiandrosterone prodrug nanoparticles loaded with camptothecin for cancer therapy by enhancing oxidation therapy and cell replication inhibition.
Topics: Camptothecin; Cell Line, Tumor; Dehydroepiandrosterone; DNA Replication; Drug Delivery Systems; Humans; Nanoparticles; Neoplasms; Oxidation-Reduction; Prodrugs | 2021 |